Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.

Purpose: The revised prescription drug labeling developed by the Food and Drug Administration (FDA) is described. Summary: A new FDA final rule, "Requirements on Content and Format of Labeling for ...

An off-label prescription drug has been shown to help some non-verbal children with autism discover the ability to speak. The drug, leucovorin, is a prescription vitamin that functions similarly ...

The FDA approved an expanded label for Iluvien, which is now indicated for the treatment of chronic noninfectious uveitis ...

A bipartisan Senate bill dubbed the “Skinny Label, Big Savings Act” was introduced in January. The bill would expand the scope of protection ...

Mounjaro (tirzepatide) is a prescription drug that may be prescribed off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight management. Mounjaro comes ...

The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the ...

The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...